Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
adhesion
13%
biopsy
13%
burnout
13%
cancer
58%
candida
13%
classification
15%
communities
15%
comparative evaluations
10%
correlations
14%
cysts
13%
detection
6%
diseases
15%
environment
27%
epidemiology
13%
fertility
48%
genotype
13%
growth factors
13%
hospitals
17%
humans
100%
indicators
6%
interventions
8%
kazakhstan
50%
lactobacillus
19%
levels
9%
malformations
13%
management
28%
men
6%
menopause
24%
mortality
7%
oocytes
16%
ovaries
29%
patients
22%
physiology
13%
pollutants
13%
populations
18%
preservation
15%
quality of life
28%
radiations
6%
reserves
8%
reviews
41%
risks
39%
screening
50%
sperm
8%
strains
13%
stratification
13%
surgery
9%
symptoms
13%
toxicity
13%
women
97%
workers
26%
Medicine and Dentistry
Assisted Reproductive Technology
6%
Biopsy Technique
13%
Burnout
13%
Cancer
7%
Cancer Epidemiology
13%
Cancer Growth Factor
13%
Cancer Immunization
13%
Cancer Incidence
7%
Cancer Screening
13%
Cancer Therapy
10%
Carcinogenesis
10%
Cervical Cancer
20%
Cervical Cancer Screening
16%
Cervix Uteri
6%
Colposcopy
16%
Congenital Malformation
13%
Cross Sectional Study
28%
Cyst
13%
Diseases
18%
Endometriosis
13%
Factor A
13%
fertility
32%
Fertility Outcome
6%
Fertility Preservation
16%
Genital Malformation
13%
Growth Factor
13%
Health Care Personnel
30%
Human Papillomavirus Type 16
7%
In Vitro Fertilisation
6%
Infection
8%
Mental Stress
10%
Myometrium
6%
Oocyte
13%
Ovarian Cancer
13%
Ovarian Cyst
10%
Ovarian Reserve
13%
Papillomavirus Infection
20%
Pathophysiology
13%
Prevalence
17%
Psychological Aspect
13%
Quality of Life
16%
Reproductive Age
11%
Risk Stratification
13%
Survival Rate
6%
Tertiary Care
13%
Treatment Option
9%
Triage
15%
Uterine Fibroid
13%
Vasculotropin
13%
Wart Virus
26%
Keyphrases
Astana
16%
Cervical Cancer
8%
Cervical Cancer Prevention
7%
Cervical Cancer Screening
13%
Co-infection
9%
Community State Type
13%
Diagnostic Methodology
13%
Diagnostic Risk
13%
Diagnostic Triage
13%
Fibroids
6%
Functional Screening
13%
Genotype Distribution
6%
Growth Factor Pathway
13%
Growth Factors
13%
Healthcare Workers
13%
High-risk Human Papillomavirus (HR-HPV)
12%
Human Papillomavirus
34%
Human Papillomavirus Genotypes
9%
Human Papillomavirus Types
13%
Infection Outcomes
5%
Infection Risk
13%
Kazakhstan
31%
L. Plantarum
8%
Lactobacillus Iners
13%
Menopausal Quality of Life
22%
Menopausal Transition
13%
Mycoplasma Hominis
5%
New Diagnostics
13%
Novel Diagnostics
7%
Papillomavirus Infections
17%
Postmenopause
6%
Prospective Cohort Study
13%
Quality of Life
13%
Risk Stratification
13%
Transforming Growth Factor-β
13%
Unvaccinated
13%
Uterine Fibroids
10%
Uterine Leiomyoma
13%
Vaginal Microbiota
13%
Vascular Endothelial Growth Factor
13%